From extricating Daiichi Sankyo from the Ranbaxy acquisition to enabling the rapid development of blockbuster Enhertu, George Nakayama has had a winding career path through multiple key strategic positions and decisions. He shares his experience and insights, and a good dose of humor, in this exclusive interview.
George Nakayama (right), former CEO of Daiichi Sankyo, received the Lifetime Achievement Award at the Citeline Pharma Intelligence Awards Japan 2023. • Source: Lisa Takagi
George Nakayama, the former president and CEO of Daiichi Sankyo Co., Ltd., is the executive who made two fate-changing decisions for the major Japanese firm.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
